Command Palette

Search for a command to run...

Clinical Trials · NCT02553603

The Effect of Growth Hormone Releasing Hormone on Cognitive Function in Individuals With Mild Cognitive Impairment

CompletedPhase 1Tesamorelin (Approved)
Phase
Phase 1
Recruitment status
Completed
Sponsor
The University of Texas Medical Branch, Galveston
Enrollment
22
Start date
Jul 2017
Locations
1 site, United States
Primary endpoint
Cognitive Function measured by SLUMS
View Tesamorelin compound reference